CN114373505A - System for early prediction of postpartum subclinical ketosis of dairy cow based on intestinal microorganisms - Google Patents

System for early prediction of postpartum subclinical ketosis of dairy cow based on intestinal microorganisms Download PDF

Info

Publication number
CN114373505A
CN114373505A CN202111639671.9A CN202111639671A CN114373505A CN 114373505 A CN114373505 A CN 114373505A CN 202111639671 A CN202111639671 A CN 202111639671A CN 114373505 A CN114373505 A CN 114373505A
Authority
CN
China
Prior art keywords
microorganisms
postpartum
ketosis
dairy
abundance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111639671.9A
Other languages
Chinese (zh)
Other versions
CN114373505B (en
Inventor
孙会增
朱森林
顾凤飞
刘建新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CN202111639671.9A priority Critical patent/CN114373505B/en
Publication of CN114373505A publication Critical patent/CN114373505A/en
Application granted granted Critical
Publication of CN114373505B publication Critical patent/CN114373505B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F18/00Pattern recognition
    • G06F18/20Analysing
    • G06F18/24Classification techniques
    • G06F18/243Classification techniques relating to the number of classes
    • G06F18/24323Tree-organised classifiers
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/04Forecasting or optimisation specially adapted for administrative or management purposes, e.g. linear programming or "cutting stock problem"
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Business, Economics & Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Human Resources & Organizations (AREA)
  • General Physics & Mathematics (AREA)
  • Strategic Management (AREA)
  • Evolutionary Biology (AREA)
  • Economics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Public Health (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Epidemiology (AREA)
  • Artificial Intelligence (AREA)
  • Development Economics (AREA)
  • Primary Health Care (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Databases & Information Systems (AREA)
  • Biomedical Technology (AREA)
  • Game Theory and Decision Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Evolutionary Computation (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Marketing (AREA)
  • Operations Research (AREA)
  • Quality & Reliability (AREA)

Abstract

The invention discloses a system for early predicting dairy cow postpartum subclinical ketosis based on intestinal microorganisms, which predicts the dairy cow postpartum subclinical ketosis by using the abundance of intestinal prognostic marker microorganisms after dairy cows in the perinatal period, wherein the prognostic marker microorganisms comprise genus level Parabacter, Shigella, Cellulosilyticum, Roseburia, Sporobacter and Acetanerobacterium. The invention screens the 6 sub-clinical ketosis prognosis marker microorganisms and establishes a prognosis discrimination model based on discrimination analysis. The kit has accurate and stable prediction capability on postpartum subclinical ketosis of the dairy cow, can be used for early warning and screening the dairy cow in the perinatal period by a noninvasive rectal sampling method, and provides an effective means for preventing and treating postpartum ketosis and subclinical ketosis of the dairy cow as early as possible in a dairy farm.

Description

System for early prediction of postpartum subclinical ketosis of dairy cow based on intestinal microorganisms
Technical Field
The invention relates to the field of perinatal dairy cow health, in particular to a system for predicting blood beta-hydroxybutyric acid level of a dairy cow in one week after delivery based on prenatal intestinal microorganisms so as to predict postnatal subclinical ketosis.
Background
The dairy cattle breeding industry in China develops rapidly in the twenty-first century, the annual single-yield level of dairy cattle rises from less than 4,000 kilograms to more than 8,000 kilograms, but the health problem is increasingly prominent along with the continuous rising of the yield of the dairy cattle. After delivery, due to the fact that the energy supplied by the feed cannot meet the requirement of milk production, cows usually have different degrees of energy negative balance, and therefore need to be supplied with energy by moving the cows from body tissues. In this process, a large amount of long-chain fatty acids in body fat are decomposed into non-esterified fatty acids which enter the liver and are not completely oxidized, free fatty acids further form ketone bodies such as BHBA, acetoacetic acid, acetone and the like, and partial long-chain fatty acids are re-esterified to form triglyceride. When a large amount of BHBA and triglyceride are accumulated in the liver, the BHBA and the triglyceride can not be utilized and removed in time, so that the lipid metabolism disorder of the dairy cow can be caused, and meanwhile, the BHBA diffuses into blood to cause metabolic diseases such as ketosis, fatty liver and the like. The incidence of ketosis of dairy cows in late perinatal period of China is reported to account for 10% -30% of lactating dairy cows, and the health of the dairy cows and the economic benefit of dairy farms are seriously harmed.
The most common determination index for ketosis is blood BHBA concentration, which can be divided into subclinical and clinical ketosis. Subclinical ketosis is defined as the postpartum disease of the dairy cow with no clinical symptoms but excessive ketone body content detected by organisms and the plasma BHBA concentration of more than 1.2 mmol/L. Research statistics total economic losses due to reduced milk production account for approximately 24%, mainly because ketosis causes hypoglycemia, which lowers lactose synthesis, resulting in reduced milk production. The sub-clinical ketosis has higher occurrence frequency and stronger concealment than the clinical ketosis, can cause economic losses in various aspects such as reduction of milk yield of cows, increase of cow elimination rate, increase of treatment cost, prolongation of calving period and the like, and reports that about 30-50% of cows can generate the sub-clinical ketosis in the late perinatal period and the early lactation period.
At present, the prevention and treatment agents and products related to subclinical ketosis and ketosis of dairy cows have been researched more, and include methods such as glucose bolus injection, glucocorticoid gluconeogenesis promotion, insulin lipolysis reduction, vitamin B12/phosphorus gluconeogenesis promotion, propylene glycol as gluconeogenesis precursor and the like, but due to the higher latency of subclinical ketosis symptoms, the prevention and treatment can be implemented without aiming at generating high cost and side effects on healthy individuals. Therefore, a simple and accurate prediction method is urgently needed to judge the dairy cattle which are prone to subclinical ketosis after delivery, so that early intervention is accurately implemented, and economic loss of the dairy cattle in the perinatal period is reduced.
The rear intestinal microorganisms are closely inseparable with the health of the organism in the research, nutrient substances are absorbed in the process that chyme of the dairy cows goes from front to back in the digestive tract, the abundance of metabolic waste is gradually increased through an accumulation effect, and the metabolic waste is accumulated in the rear intestinal tract. In human and monogastric animal studies, posterior intestinal microorganisms are induced by equiaxial induction of intestine-brain, intestine-liver and intestine-heart or participate in health regulation of the body, and a large number of novel microbial markers are reported. With the rapid development of the microbial 16S rRNA gene sequencing technology, it is possible to obtain the marker microorganism by microbial sequencing. Among the existing ruminant studies, research on microorganisms in the forestomach is very abundant, and microorganisms in the forestomach are proved to be associated with the production performance of cows, such as milk yield, milk protein content and nitrogen metabolism efficiency, feed conversion efficiency, and the like. The latter intestinal microorganisms are considered to be closely related to diseases and physiological states of the cow body, but related research reports are very poor. The potential value of intestinal microorganisms on the regulation and prediction of the health of the dairy cows needs to be excavated.
The invention successfully establishes a machine learning model for predicting the blood BHBA concentration of one week postpartum based on the intestinal marker microorganisms of the antenatal cows for the first time, and has higher model efficiency (AUROC:0.876-0.917 (95% CI 0.778-0.993)) and Accuracy (Accuracy: 0.839-0.857). The invention provides a novel solution for accurate prevention and treatment of postpartum ketosis, and has important guiding significance and application value for accurately relieving metabolic burden of high-yield dairy cows in perinatal period, improving stress state and improving health and production level.
Disclosure of Invention
The invention aims to provide a system for early predicting the postpartum subclinical ketosis of a dairy cow based on intestinal microorganisms aiming at the defects of the prior art, and provides a machine learning model for predicting the postpartum blood BHBA concentration of a week on the basis of the intestinal marker microorganisms of a prenatal dairy cow, which has higher model efficiency and accuracy.
The purpose of the invention is realized by the following technical scheme: a system for early predicting postpartum subclinical ketosis of a cow based on intestinal microorganisms comprises a microorganism collecting module and a postpartum blood beta-hydroxybutyric acid predicting module;
the microorganism collection module is used for collecting microorganisms of 3 weeks before birth of the dairy cow and inputting the microorganisms into the postpartum blood beta-hydroxybutyric acid prediction module, wherein the microorganisms are prognosis marker intestinal microorganisms and comprise six microorganisms, namely Parabacteriaceae, Shigella, Cellulosilyticum, Roseburia, Sporobacter and Acetanerobacterium;
the postpartum blood beta-hydroxybutyric acid prediction module comprises a discrimination model for predicting the postpartum blood beta-hydroxybutyric acid level of a cow in one week, wherein the discrimination model comprises the following specific steps:
Figure BDA0003443577120000021
wherein g isiFor the discrimination coefficient, the numerical values are shown in the following table; abundannceiInputting data for a discrimination model, and obtaining genus level abundance obtained by sequencing the 16S rRNA gene of the ith microorganism in prenatal rectal contents of the dairy cows; score represents the Score obtained by the discriminant model even after inputting the genus-level abundance of 6 microorganisms. When Score is measured>At-0.004, cows are considered to be at risk of developing subclinical ketosis one week post partum.
Marker microorganism Coefficient gi
Parabacteroides 0.502
Shigella -11.255
Cellulosilyticum 2.669
Roseburia 2.202
Sporobacter -19.538
Acetanaerobacterium -8.803
Furthermore, for all microorganism samples in the intestinal tracts of the cows in three weeks before birth, a sample with the abundance higher than 0.01% in 50% of the samples is selected, all the microorganisms in three weeks before birth are subjected to characteristic screening of postpartum subclinical ketosis prediction effectiveness by a random forest Boruta method, and the first 6 microorganisms are obtained according to the minimum variable number (6) with the lowest error rate obtained by cross validation and the ranking of the mean Gini index (MeanecreaseGini).
Further, the genus-level abundance of the microorganism is the amplified abundance of the 16S rRNA gene V3-V4 region of the microorganism.
Further, the coefficient of discrimination giThe abundance of the microbial marker fragment in the variable region V3-V4 of the 16S rRNA gene of 6 microorganisms was obtained by classical discriminant analysis (Canonical diagnostic analysis).
Further, the determination method of the abundance of the microorganism characteristic fragments in the 16S rRNA gene variable region V3-V4 region of the marker microorganism comprises but is not limited to PCR, amplicon sequencing, second-generation high-throughput sequencing, Panomics or Nanostring metagenome sequencing.
The method has the advantages that the method can predict the disease condition of subclinical ketosis of the dairy cattle after delivery and carry out early warning diagnosis by utilizing the discrimination model of the invention through detecting the abundance of the microorganism characteristic fragments of the 16S rDNA variable region V3-V4 of the dairy cattle hindgut marker microorganisms (Parabacteroides, Shigella, Cellulosidium, Roseburia, Sporobacter and Acetaceae) 3 weeks before delivery, thereby being helpful for reducing the disease condition by taking effective prevention and control measures before diseases and laying a foundation for accurate prevention and control of the dairy cattle in the perinatal period. The invention provides a novel solution for accurate prevention and treatment of postpartum ketosis, and has important guiding significance and application value for accurately relieving metabolic burden of high-yield dairy cows in perinatal period, improving stress state and improving health and production level.
Drawings
Fig. 1 is a case where cows were grouped into values according to BHBA one week postpartum, healthy group one week postpartum and subclinical ketosis group.
Fig. 2 is an error rate curve drawn after 5 times of cross validation using a random forest method, and the dividing line shows that when the number of variables is 6, the error rate can be guaranteed to be the lowest and the number of variables is the smallest.
FIG. 3 is a graph of the importance of microbial variables ranked by the MeanGini index of the random forest model and the top 6 species at the genus level were selected.
FIG. 4 is a graph showing that there were significant differences in the abundance of 5 microorganisms between individuals who developed sub-clinical ketosis postpartum and those who did not developed sub-clinical ketosis three weeks prenatal under the differential t test.
FIG. 5 is an ROC curve for discriminant analysis prediction model prediction based on cross validation performance testing of the discriminant analysis prediction model.
Fig. 6 is a system block diagram of the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and the described embodiments are only a part of the embodiments of the present invention, but not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
As shown in figure 6, the invention provides a system for predicting postnatal subclinical ketosis based on prenatal intestinal microorganisms of dairy cows, which comprises a microorganism collection module and a postnatal blood beta-hydroxybutyric acid prediction module; as shown in fig. 1, prior to predicting total BHBA levels in postpartum blood, blood sample collection and indicator determinations were first performed as follows:
1. posterior intestinal content Collection
54 cows with the age, body condition and gestational age similar to those in Hangzhou intensive dairy farms are selected, the cows are tracked, and a rectal stool taking method is adopted before the cows are fed three weeks before parturition and one week after parturition, and the feces are taken out from the rectum and immediately quenched in liquid nitrogen. All stored in an ultra-low temperature refrigerator at-80 ℃ before 16SrDNA assay.
2. Plasma collection and routine blood analysis
When the fecal microorganisms are collected, blood samples are collected from tail vein blood vessels of the dairy cows in an EDTA vacuum blood collection tube, and a low-temperature centrifuge is started in advance, wherein the set temperature is 4 ℃. Immediately after blood collection, the plasma was obtained by centrifugation at 3000 Xg for 15 minutes at 4 ℃ and the uppermost layer of plasma was aspirated by a 1mL pipette, and the plasma was kept in 1.5mL centrifuge tubes and placed in a-80 ℃ refrigerator. A multi-sample automated assay was initiated using a Hitachi 7020 full-automatic biochemical analyzer (High-technologies corporation, Tokyo, Japan) and a matched biochemical kit (Ningbo Medical System Biotechnology co., Ltd), and the total BHBA level in plasma of each sample was determined one week after birth. Taking the subclinical ketosis standard of 1.2mmol/L in the dairy cow industry as a two-classification grouping demarcation point, the dairy cow with the total BHBA level in blood lower than 1.2umol/L is defined as a normal dairy cow, the dairy cow with the total BHBA level higher than 1.2umol/L is defined as a dairy cow with subclinical ketosis, and the dairy cow with the clinical ketosis, namely the total BHBA level higher than 2.0mmol/L, does not appear in the group.
The method comprises the following steps of (1) screening marker microorganisms based on the microbial genus level, and collecting the screened marker microorganisms through a microorganism collecting module;
subsequent analysis was performed using the genus-level annotated abundance information of microorganisms obtained after 16S rRNA gene sequencing, and 73 species-level microorganisms remained after removing low-abundance species with abundance below 0.01% in 50% of the samples. Since the individual number of subclinical ketosis and normal cows in one week after delivery is 6:39 respectively, and the number of samples between groups is very different, the two groups of unbalanced samples are subjected to balance expansion by using the SMOTE method in the DMwR package. The parameters of the SMOTE method are chosen to be per 500, per 300.
After sample equilibration, a Boruta variable screening method for random forests was performed based on the prenatal three weeks of microbes, and the variable identified as "verified" was selected. And performing random forest prediction modeling by using an R packet of RandomForest. Inputting variables into a randomForest function by using a random forest R packet to construct a random forest model, performing characteristic screening of postpartum subclinical ketosis prediction effectiveness on all prenatal microorganisms in three weeks by using a random forest Boruta method, performing cross validation for 5 times by using an rfcv function of the R packet, drawing an error rate curve, observing the change relationship between the error rate and the number of used Markers as shown in figure 2, and selecting 6 variables with the minimum variables and the lowest prediction error rate. After removing the genus-level microorganisms not classified under 16S rRNA gene sequencing, the top 6 microbial genera were selected as in figure 3 based on random forests in the variable importance ranking by means of meanderiesegini ranking: parabacteroides, Shigella, Cellulosilyticum, Roseburia, Sporobacter, Acetanerobacterium as marker microorganisms, the functions of which are shown in Table 1 below.
TABLE 1 six markers of intestinal microbial function
Figure BDA0003443577120000051
The differential t-test in figure 4 shows that there are significant differences in the abundance of 5 microorganisms between postpartum healthy and subclinical ketosis individuals three weeks prior to delivery. The postpartum blood beta-hydroxybutyric acid prediction module comprises a discrimination model, and the specific construction process is as follows:
because the random forest model is an integrated model based on bagging, the model is composed of tens of hundreds of decision trees, and the model needs to be stored in a form of programming language objects, is difficult to popularize in livestock production and diagnosis, and cannot obtain a prediction result through rapid manual calculation. Therefore, the abundance matrix of 6 microorganisms collected by the microorganism collecting module is used for classical discriminant analysis (Canonical diagnostic analysis) to obtain a post-natal subclinical ketosis prediction discriminant calculation formula which can be operated based on the abundance of the marker microorganisms. The discriminatory model is defined as a linear combination of microbial abundances of marker microorganisms. The calculation formula is as follows:
Figure BDA0003443577120000052
Figure BDA0003443577120000053
Figure BDA0003443577120000061
in the formula, a coefficient g is discriminatediAs shown in the above table, AbundannceiThe abundance of microorganism characteristic fragments of the 16S rRNA gene variable region V3-V4 region of the microorganism is marked in the i-th microorganism three weeks before and after birth. The Score value obtained by calculation is used for calculating posterior probability through the following Bayesian formula,
P(k|X)∝P(X|k)*P(k)
where k represents the probability of onset of subclinical ketosis, P (k) is the prior probability, and the likelihood P (X | k) is the probability of the occurrence of the target predictor variable X in each class (onset versus non-onset). Likelihood is calculated by projecting data onto a discriminant function, and based on the distribution of discriminant function values, calculating normal distributions N (mu) dependent on different kinds of discriminant values using the fittistr function in MASS packets in R11 2) And N (mu)22 2) The Score cut is estimated based on the probability density function of two types of normal distributions, incidence and non-incidence. Calculated at Score less than-0.004, only 0.001 probability is encountered one week after delivery. When Score is greater than-0.004, the cow is considered to be at risk of developing subclinical ketosis postpartum.
Cross validation and performance testing of the models:
and (3) performing performance test on the discriminant analysis prediction model by using cross validation, wherein the ROC curve of model prediction is shown in FIG. 5, calculating the AUROC values of the model Accuracy and AUROC of each fold of cross validation based on a confusion matrix, and after the cross validation, the AUROC range of the discriminant model is AUROC:0.876-0.917 (95% CI: 0.778-0.993), and the Accuracy is 0.839-0.857. The Accuracy of the typical discriminant prediction system in each refraction cross validation is greater than 0.839, and the AUC is greater than 0.870.
The implementation case is as follows:
randomly collecting the contents of the intestinal tracts of the cows in three weeks before birth in an intensive pasture in Hangzhou through a microorganism collecting module, sequencing the 16S rRNA to obtain the abundances of six microorganisms, evaluating the abundances by using a discrimination model, and predicting the accuracy to be 0.818, as shown in table 2, wherein the implementation effect of the table 2 based on 6 marker microorganisms is shown in table 2
Dairy cow numbering 1 2 3 4 5 6 7 8 9 10 11
g__Cellulosilyticum 0.67 0.21 0.19 0.07 0.64 0.17 0.16 0.21 0.1 0.16 0.25
g__Parabacteroides 0.18 0.44 0.28 0.64 0.45 0.6 0.64 0.43 0.58 0.51 0.44
g__Roseburia 0.09 0.26 0.27 0.11 0.24 0.23 0.24 0.16 0.31 0.3 0.2
g__Shigella 0.01 0.07 0.15 0.02 0.01 0.02 0.02 0 0.04 0.03 0.01
g__Acetanaerobacterium 0.01 0.07 0.04 0.05 0.04 0.08 0.09 0.02 0.01 0.01 0.04
g__Sporobacter 0.06 0.07 0.04 0.06 0.06 0.03 0.04 0.03 0.02 0.03 0.04
Score 1.51 -0.8 -1 -0.3 1.6 0.51 0.08 1.04 0.98 0.96 0.77
Actual onset of disease 0 0 0 1 1 1 1 1 1 1 1
Conjecture of postpartum onset of disease 1 0 0 0 1 1 1 1 1 1 1
In conclusion, the method calculates and predicts the risk probability of postpartum occurrence of the test sample according to the discriminant model through the intestinal microbial abundances of the six dairy cows, namely Parabacteroides, Shigella, Cellulositicum, Roseburia, Sporobacter and Acetanaerobacter, and provides a basis for health maintenance and early warning of the dairy cows.
The above-described embodiments are intended to illustrate rather than to limit the invention, and any modifications and variations of the present invention are within the spirit of the invention and the scope of the appended claims.

Claims (5)

1. A system for early predicting postpartum subclinical ketosis of a cow based on intestinal microorganisms is characterized by comprising a microorganism collecting module and a postpartum blood beta-hydroxybutyric acid predicting module;
the microorganism collection module is used for collecting intestinal microorganisms of the dairy cows in 3 weeks before birth and inputting the intestinal microorganisms into the postpartum blood beta-hydroxybutyrate prediction module, and the microorganisms are intestinal microorganisms with prognosis markers, including six microorganisms, namely Parabacteroides, Shigella, Cellulosilyticum, Roseburia, Sporobacter and Acetanerobacterium;
the postpartum blood beta-hydroxybutyric acid prediction module comprises a discrimination model for predicting the postpartum blood beta-hydroxybutyric acid level of a cow in one week, wherein the discrimination model comprises the following specific steps:
Figure FDA0003443577110000011
wherein g isiFor the discrimination coefficient, the numerical values are shown in the following table; abundannceiInputting data for a discrimination model, and obtaining genus level abundance obtained by sequencing the 16S rRNA gene of the ith microorganism in prenatal rectal contents of the dairy cows; score represents the Score calculated by the discriminant model after inputting the genus-level abundance of 6 microorganisms. When Score is measured>At-0.004, cows are considered to be at risk of developing subclinical ketosis one week post partum.
Marker microorganism Coefficient gi Parabacteroides 0.502 Shigella -11.255 Cellulosilyticum 2.669 Roseburia 2.202 Sporobacter -19.538 Acetanaerobacterium -8.803
2. The system for early predicting the postpartum subclinical ketosis of the dairy cattle according to claim 1, wherein for all microorganism samples in the intestinal tract of the dairy cattle before three weeks of birth, a sample with an abundance of more than 0.01% in 50% of the samples is selected, and after the feature screening of the efficacy of predicting the postpartum subclinical ketosis is performed on all the microorganisms before three weeks of birth by the random forest Boruta method, the first 6 microorganisms are obtained according to the minimum variable number (6) with the lowest error rate obtained by cross validation and the high-low ranking (MeanecreaseGini) of the average Gini index.
3. The system for early predicting postpartum subclinical ketosis of a cow based on intestinal microorganisms of claim 1, wherein the genus level abundance of the microorganisms is the amplified abundance of the 16S rRNA gene V3-V4 region of the microorganisms.
4. The system for early predicting dairy cow postpartum subclinical ketosis based on intestinal microorganisms of claim 1, wherein the coefficient of discrimination g isiThe abundance of the microbial marker fragment in the variable region V3-V4 of the 16S rRNA gene of 6 microorganisms was obtained by classical discriminant analysis (Canonical diagnostic analysis).
5. The system for early predicting postpartum subclinical ketosis of a cow according to claim 4, wherein the determination method of the abundance of the microorganism characteristic fragments in the variable region V3-V4 of the 16S rRNA gene of the marker microorganism comprises but is not limited to PCR, amplicon sequencing, next generation high-throughput sequencing, Panomics or Nanostring metagenomic sequencing.
CN202111639671.9A 2021-12-29 2021-12-29 System for early prediction of postpartum subclinical ketosis of dairy cow based on intestinal microorganisms Active CN114373505B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111639671.9A CN114373505B (en) 2021-12-29 2021-12-29 System for early prediction of postpartum subclinical ketosis of dairy cow based on intestinal microorganisms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111639671.9A CN114373505B (en) 2021-12-29 2021-12-29 System for early prediction of postpartum subclinical ketosis of dairy cow based on intestinal microorganisms

Publications (2)

Publication Number Publication Date
CN114373505A true CN114373505A (en) 2022-04-19
CN114373505B CN114373505B (en) 2022-11-01

Family

ID=81142636

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111639671.9A Active CN114373505B (en) 2021-12-29 2021-12-29 System for early prediction of postpartum subclinical ketosis of dairy cow based on intestinal microorganisms

Country Status (1)

Country Link
CN (1) CN114373505B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114854884A (en) * 2022-05-27 2022-08-05 山东农业大学 Method for early warning or noninvasive diagnosis of fatty liver dairy cow by using fecal microorganisms belonging to level

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070026493A1 (en) * 2005-07-27 2007-02-01 Can Technologies, Inc. System and method for optimizing animal production using genotype information
CN105407728A (en) * 2013-07-21 2016-03-16 霍勒拜欧姆公司 Methods and systems for microbiome characterization, monitoring and treatment
CN106537145A (en) * 2014-04-08 2017-03-22 麦特博隆股份有限公司 Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment
CN110144415A (en) * 2019-04-23 2019-08-20 大连大学 One kind introducing milk cow health and immunity level method based on intestinal flora prediction
CN112852916A (en) * 2021-02-19 2021-05-28 王普清 Marker combination for intestinal microecology, auxiliary diagnosis model and application of marker combination
CN112841431A (en) * 2021-03-17 2021-05-28 西北农林科技大学 Compound formula for preventing and treating dairy cow ketosis suitable for oral administration

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070026493A1 (en) * 2005-07-27 2007-02-01 Can Technologies, Inc. System and method for optimizing animal production using genotype information
CN105407728A (en) * 2013-07-21 2016-03-16 霍勒拜欧姆公司 Methods and systems for microbiome characterization, monitoring and treatment
CN106537145A (en) * 2014-04-08 2017-03-22 麦特博隆股份有限公司 Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment
CN110144415A (en) * 2019-04-23 2019-08-20 大连大学 One kind introducing milk cow health and immunity level method based on intestinal flora prediction
CN112852916A (en) * 2021-02-19 2021-05-28 王普清 Marker combination for intestinal microecology, auxiliary diagnosis model and application of marker combination
CN112841431A (en) * 2021-03-17 2021-05-28 西北农林科技大学 Compound formula for preventing and treating dairy cow ketosis suitable for oral administration

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A SAMIEI ET AL: "《An Evaluation of β-hydroxybutyrate in Milk and Blood for Prediction of Subclinical Ketosis in Dairy Cows》", 《POLISH JOURNAL OF VETERINARY SCIENCE》 *
黄云飞: "《基于肠道微生物测序和灌服原花青素对奶牛酮病的研究》", 《中国博士学位论文全文数据库农业科技辑》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114854884A (en) * 2022-05-27 2022-08-05 山东农业大学 Method for early warning or noninvasive diagnosis of fatty liver dairy cow by using fecal microorganisms belonging to level

Also Published As

Publication number Publication date
CN114373505B (en) 2022-11-01

Similar Documents

Publication Publication Date Title
Costa et al. Genetic associations of lactose and its ratios to other milk solids with health traits in Austrian Fleckvieh cows
CN108345768B (en) Method for determining maturity of intestinal flora of infants and marker combination
CN108778287B (en) Methods and systems for early risk assessment of preterm birth outcomes
Diaz et al. Analysis of the influence of variation factors on electrical conductivity of milk in Murciano-Granadina goats
Plancade et al. Unraveling the effects of the gut microbiota composition and function on horse endurance physiology
Urioste et al. Phenotypic and genetic characterization of novel somatic cell count traits from weekly or monthly observations
CN108511056A (en) Therapeutic scheme based on patients with cerebral apoplexy similarity analysis recommends method and system
CN114373505B (en) System for early prediction of postpartum subclinical ketosis of dairy cow based on intestinal microorganisms
CN111681209A (en) Intelligent detection method and system for cleavage state of blastomere
Kulkarni et al. Survival analysis of dairy cows in the Netherlands under altering agricultural policy
Golder et al. Characterizing ruminal acidosis risk: A multiherd, multicountry study
CN110501443B (en) Novel biomarker for noninvasive identification/early warning of fatty liver cows
CN116913551A (en) System and method for predicting anti-tuberculosis drug-induced liver injury
Wisnieski et al. Cohort-level disease prediction using aggregate biomarker data measured at dry-off in transition dairy cattle: A proof-of-concept study
Mach et al. The first horse gut microbiome gene catalog reveals that rare microbiome ensures better cardiovascular fitness in endurance horses
Lopreiato et al. Suitability of rumination time during the first week after calving for detecting metabolic status and lactation performance in simmental dairy cows: a cluster-analytic approach
CN114371280A (en) Plasma biomarker for broiler AFB1 poisoning diagnosis and application thereof
CN114512231A (en) Down syndrome screening system based on cascade characteristic selection algorithm
Wang et al. Precowketosis: a shiny web application for predicting the risk of ketosis in dairy cows using prenatal indicators
Madouasse An evaluation of milk recording, somatic cell counts and reproductive performance in a large cohort of dairy herds in England and Wales
Wang et al. Weighted Gene Co-expression Network Analysis Identifies Specific Modules and Hub Genes Related to Subacute Ruminal Acidosis
Semenenko et al. Methodology of development and diagnostic efficiency of expert systems in animal hepatopathies
Jusman et al. Comparison Performance of Prostate Cell Images Classification using Pretrained Convolutional Neural Network Models
CN111506881B (en) System for predicting Chinese Holstein cow mastitis onset risk
US20230048974A1 (en) Systems and methods for improving livestock health and performance

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant